-
Thomson American Health Consultants is happy to announce that we are opening up our Primary Care Reports author process to our readers. A biweekly newsletter with approximately 5000 readers, each issue is a fully referenced, peer-reviewed monograph.
-
The ECG in the Figure was obtained from a 73-year-old man with documented coronary disease and heart failure. He now presents with a 10-day history of dyspnea. How would you interpret his ECG?
-
Rapid Magnetic Resonance Imaging vs Radiographs for Patients with Low Back Pain; Effectiveness of Anticholinergic Drugs Compared with Placebo in the Treatment of Overactive Bladder; A Randomized Trial of a Low Carbohydrate Diet for Obesity
-
The FDA recently approved gefitinib, an inhibitor of tyrosine kinase activity of the epidermal growth factor receptor, for the treatment of non-small-cell lung cancer.
-
Compared with abstention, consumption of 1-6 drinks weekly of alcoholic beverages was associated with a lower risk of dementia among adults older than 65 years.
-
A warfarin initiation nomogram that uses 10 mg as a starting dose achieves a therapeutic INR more rapidly than one using a 5-mg starting dose.
-
Over a 5-year period, the incidence of developing sleep-disordered breathing (AHI > 5 events/hr) is about 37%, about 7% per year. With aging, male gender and body mass index (BMI) lose importance as risk factors for obstructive sleep apnea.
-
Increase in Blood Glucose Concentration During Antihypertensive Treatment as a Predictor of Myocardial Infarction; Adverse Drug Events in Ambulatory Care; Prevention of Hip Fracture by External Hip Protectors
-
Aripiprazole is a new antipsychotic agent approved for the treatment of schizophrenia. This atypical agent is a quinolinone that has partial agonist activity at dopamine D2 receptors. The drug will be marketed as being better tolerated and safer than other atypical agents, as well as being dosed once a day.
-
Cirrhosis-related parkinsonism may represent a unique, consistent, and common subset of acquired hepatocerebral degeneration, whose features are permanent and entirely different from acute hepatic encephalopathy episodes.